Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid  by Kim, A. et al.
at SciVerse ScienceDirect
Placenta 34 (2013) 873e878Contents lists availablePlacenta
journal homepage: www.elsevier .com/locate/placentaIdentiﬁcation of biomarkers for preterm delivery in mid-trimester
amniotic ﬂuidqq
A. Kim a, E.S. Lee b, J.C. Shin c,**,1, H.Y. Kim d,*,1
aDepartment of Obstetrics and Gynecology, Institute of Wonkwang Medical Science, College of Medicine, Wonkwang University, Iksan, Republic of Korea
bDepartment of Obstetrics and Gynecology, College of Medicine, SoonChunHyang University, Seoul, Republic of Korea
cDepartment of Obstetrics and Gynecology, College of Medicine, Seoul, Republic of Korea
dDepartment of Obstetrics and Gynecology, College of Medicine, Kosin University, Busan, Republic of Koreaa r t i c l e i n f o
Article history:
Accepted 24 June 2013
Keywords:
Preterm birth
MMP-8
IL-6
VEGF
Amniotic ﬂuidqq This study was supported by a grant from Kosin
(2012).
* Corresponding author. Tel.: þ82 51 990 6226; fax
** Corresponding author. Tel.: þ82 2 590 2749; fax:
E-mail addresses: ttochil@hanmail.net (J.C. Shin), hy
1 The last two authors equally contributed to this w
0143-4004  2013 The Authors. Published by Elsevie
http://dx.doi.org/10.1016/j.placenta.2013.06.306a b s t r a c t
Objective: We investigated whether the level of vascular endothelial growth factor (VEGF) and inﬂam-
matory markers in mid-trimester amniotic ﬂuid have predictive value for spontaneous preterm birth in
singleton pregnancy.
Method: Our subjects were 72 pregnant women who were undertaken with amniocentesis from 16 to 19
weeks of gestation. 36 cases were women with preterm delivery, and other 36 cases were matched
women with full-term delivery. Stored amniotic ﬂuid was investigated after the delivery. The levels of
matrix metalloproteinases-8 (MMP-8), interleukin-6 (IL-6), C-reactive protein (CRP), and VEGF were
measured by enzyme-linked immunosorbent assay (ELISA) and Western blot.
Results: The levels of MMP-8 and IL-6 in preterm group were signiﬁcantly higher than control group
(5.76  1.53 ng/ml vs 4.89  1.77 ng/ml and 170.54  55.69 pg/ml vs 141.92  57.21 pg/ml, respectively)
(p < 0.05). In terms of VEGF, the levels were elevated in preterm group (30.76  4.06 pg/ml vs
22.36  7.03 pg/ml) (p < 0.05).
Conclusion: This study suggests that elevated levels of IL-6 and MMP-8 in amniotic ﬂuid at mid-trimester
are predictive of preterm delivery, and that VEGF which is representative of angiogenesis can be a new
and useful predictor of preterm delivery.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Preterm birth is an important obstetric problem that causes
considerable costs to healthcare systems. Also preterm-birth-
associated perinatal morbidities, which are responsible for almost
half of all long-term neurological disabilities, and neonatal mor-
talities reap a huge ﬁnancial and emotional burden for the affected
families. Preterm birth is deﬁned as delivery that occurs before 37th
weeks of gestation; it accounts for 10% of all pregnancies [1]. Over
the last 25 years, there has been an increase in intensive research in
this area because of a rising number of medically-indicated pretermUniversity College of Medicine
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r Ltd. Open access under CC BY-NC-Nbirths in singletons, and because of increased instances of preterm
delivery of multiple pregnancies conceived with assisted repro-
ductive technology (ART) [2].
Preterm delivery is responsible for a signiﬁcant percentage of
neonatal morbidity and mortality. The etiology of preterm birth is
unknown and is likely associated with multifactorial causes, in-
cluding infection stress and demographic factors. Therefore, ef-
forts have been made to identify predictors of preterm birth,
especially since some of the causes of preterm delivery can be
treated [1].
Biomarkers have been deﬁned as ‘’parameters, which can be
measured in a biological sample, and which provide information on
potential effects of that exposure” [3]. Based on the known risk
factors and pathways of preterm birth, several biomarkers have
been tested to see if they can predict spontaneous preterm birth.
Among those risk factors evaluated to date, fetal ﬁbronectin in
cervicovaginal ﬂuid and ultrasound assessment of cervical length
have been most strongly and consistently associated with subse-
quent spontaneous preterm birth. The test is most accurate in
predicting spontaneous preterm birth within 7e10 days of a
woman presenting with symptoms [4].D license.
Table 1
Clinical and demographic characterizations of the subjects.
Clinical characteristics Preterm delivery
(n ¼ 36)
Term delivery
(n ¼ 36)
p-value
Maternal age (years) 34.8  4.3 33.2  4.3 0.855a
BMI (kg/m2) 21.7  2.5 21.2  0.3 0.862a
Gravidity 1.08  0.33 0.93  0.46 0.156a
Gestational age at
sampling (weeks)
18.3  0.2 18.0  0.2 0.673a
Sex (male/female) 19/17 16/20 0.638b
Indication of amniocentesis
Advanced maternal age 2 2 0.938c
Abnormal quad/triple test 29 30
History of fetal anomaly 5 4
Results are expressed as mean  SD. BMI, body mass index.
a Student’s t-test.
b X2 test.
c Fisher’s exact test.
A. Kim et al. / Placenta 34 (2013) 873e878874An inﬂammatory response and microbial invasion of the am-
niotic cavity are generally regarded as a pathologic state associated
with preterm labor [2]. The molecular mechanisms by which
intrauterine inﬂammation causes preterm labor are not well un-
derstood, although a number of cytokines, chemokines, and in-
ﬂammatory mediators have been implicated. And inﬂammatory
cells have been known to secret a plethora of proangiogenic factors
including VEGF [5]. Until now, no other biomarkers have been
consistently found to be useful in clinical settings to predict
spontaneous preterm birth in asymptomatic women, especially at
mid-trimester [6]. In this reason, the study aimed to identify and
determine the accuracy of matrix metalloproteinases-8 (MMP-8),
interleukin-6 (IL-6), and C-reactive protein (CRP), for inﬂammatory
markers and vascular endothelial growth factor (VEGF) for an
angiogenic marker in mid-trimester amniotic ﬂuid for the predic-
tion of spontaneous preterm birth in women with singleton
pregnancies.
2. Materials and methods
2.1. Study design
The research was designed to be a prospective study. Collection of amniotic ﬂuid
samples from January 2009 to June 2012 and clinical data were approved by the
Institutional Review Board of Kosin Medical Center. All patients gave written
informed consent, in accordance with the Helsinki criteria. After excluding fetal
aneuploidies, anomalies, and cases who experienced pregnancy loss within 30 days
of amniocentesis, we enrolled and stored the samples of amniotic ﬂuid for later
analysis. Post-delivery patient obstetric data were reviewed, and the clinical out-
comes were obtained. Gestational age was determined based on the last menstrual
period and the ﬁrst trimester obstetric ultrasound evaluation (crown rump length at
7e9 weeks). Preterm delivery was deﬁned as birth before 37 weeks of gestation.
2.2. Patients
A total of 526 pregnant women with singleton gestations were carried out
amniocentesis and their samples of amniotic ﬂuid were stored until delivery.
Amniocentesis was performed for proper clinical indications (advanced maternal
age, abnormal quad/triple test, family history of chromosomal abnormalities, sus-
pected fetal anomalies or viral infection, and maternal request) at 16e19 weeks of
gestation. Among 526 women with available samples of amniotic ﬂuid, the study
included 72 women for study objects. Patients were invited to donate amniotic ﬂuid
for research purposes. The clinical outcome was obtained by chart review. Inclusion
criteria were uneventful pregnancy course before the procedure, absence of
congenital fetal malformations, absence of clinical signs of infection, normal volume
of amniotic ﬂuid as assessed by ultrasound, and healthy pregnant woman without
chronic or medical disease. Any preterm delivery associated with an obstetrical
complication, such as hypertensive disorders in pregnancy, obstetrical hemorrhage,
fetal growth restriction, or premature rupture of the membrane, was excluded from
the amniotic ﬂuid analysis.
We retrieved samples from every case known to have resulted in delivery before
37weeks of gestation (n¼ 36) and 36 control samples fromwomenwho delivered at
37 weeks of gestation. The control samples were matched with the preterm group
at a 1:1 ratio from sampling until testing (storage time). Matches were based on
maternal age, gestational age (weeks) at the time of amniocentesis, and the indi-
cation for the procedure.
2.3. Collection of amniotic ﬂuid and storage
Transabdominal amniocentesis was performed with a 21-gauge needle under
ultrasound guidance to evaluate the position of the fetus. Amniotic ﬂuid was ﬁrst
taken for further diagnostic testing, depending on the indication of the invasive
procedure. Afterward, 5 ml from a total volume of 20 ml of amniotic ﬂuid was
collected for research purposes. Samples were transported immediately to the
laboratory in a capped sterile syringe; amniotic ﬂuid samples were then centrifuged
for 10 min at 400rpm and stored in aliquots at 70 C until analysis at the
completion of follow-up.
2.4. Enzyme-linked immunosorbent assay (ELISA)
Invitrogen assay kits (Carlsbad, CA, USA) were used for measuring matrix MMP-
8, IL-6, CRP, and VEGF. These kits are based on the solid phase sandwich enzyme-
linked immunosorbent assay (ELISA) method. During the ﬁrst incubation, samples
were pipetted into wells coated with antibodies speciﬁc for human MMP-8, IL-6,
CRP, and VEGF, followed by the addition of a biotinylated second antibody. Duringthe ﬁrst incubation, the human antigen bound simultaneously to the immobilized
(capture) antibody on one site and to the solution phase-biotinylated antibody on a
second site.
After washing, streptavidin-peroxidase (enzyme) was added, which binds to the
biotinylated antibody to complete the four-member sandwich. After a third incu-
bation and wash to remove all the unbound enzyme, a substrate solutionwas added,
which is acted upon by the bound enzyme to produce color. The intensity of this
colored product is directly proportional to the concentrations of MMP-8, IL-6, CRP,
and VEGF present in the specimen.
The coefﬁcients of variation (CV) of intra-assay and inter-assay precision were
8.5e10.2% for MMP-8, 5.0e5.6% for IL-6, 6.0e9.9% for CRP, and 5.1e9.8% for VEGF,
respectively. The minimum detectable doses of MMP-8, IL-6, CRP, and VEGF were <
6 pg/ml, 2 pg/ml, 10 pg/ml, and 5 pg/ml, respectively.
2.5. Western blot
A total of 1e2 mL of amniotic ﬂuid was prepared by dilution with sodium
dodecyl sulfate (SDS) loading buffer (Fermentas, Waltham, MA, USA), followed by
boiling and cooling. The AF samples underwent electrophoresis in a 13.5% sodium
dodecyl sulfate-polyacrylamide gel (SDS-PAGE) (Koma Biotech, Seoul, Korea).
Thereafter, proteins were electrotransferred to a polyvinylidene diﬂuoride (PVDF)
membrane (Millipore, Billerica, MA, USA) at 30 V for 1 h. Nonspeciﬁc binding was
blocked for 1 h in noise-cancelling reagents (Millipore). After washing, membranes
were incubated for 2 h at room temperature with antibodies. The antibodies used
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) were goat anti-human MMP-8
antibody (M-20), mouse anti-human IL-6 antibody (E-4), rabbit anti-human CRP
antibody (c-12), and rabbit anti-human VEGF antibody (147). A BCIP/NBT tablet
(SigmaeAldrich, St Louis, Missouri) dissolved in distilled water was used as growth
substrate. Chemiluminescence analysis was conducted with Luminata Crescendo
Western HRP substrate (Millipore) and autoradiography ﬁlm (Agfa-Gevaert, Mortsel,
Belgium), according to the manufacturer’s instructions. The experiment was repli-
cated three times. Bands produced from the Western blot were showed using Gel
Doc XRþ with Image Lab software (Bio-Rad, Hercules, CA, USA).
2.6. Statistical analyses
Results are expressed as mean and standard deviation according to the distri-
bution of data. KolmogoroveSmirnov’s test was used to evaluate the normality of
the distribution of the continuous data. Comparisons between two groups were
conducted using Student’s t-test in a normal distribution. Univariate analyses were
performed using X2 test and Fisher’s exact test to evaluate the association of preterm
birth with factors categorized. The receiver operating characteristic (ROC) curve was
applied to calculate each factor’s predictive value for preterm delivery. SPSS version
19.0 (SPSS Inc., Chicago, IL, USA) was used for statistical calculations. P < 0.05 was
considered statistically signiﬁcant.
3. Results
Thirty-six patients delivered at <37 weeks gestation; all spon-
taneous preterm labors included an intact membrane. The included
cases were classiﬁed into the preterm group. The matched control
group included 36 healthy pregnancies with full-term delivery.
Table 1 shows the clinical and demographic characteristics of the
study samples. There were no signiﬁcant differences between the
preterm delivery group and controls with respect to the mother’s
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index, neonatal sex, indication of amniocentesis, or gravidity.
In comparing biomarkers between the preterm and full-term
groups, we found the following mean values: MMP-8 levels were
5.76 ng/ml and 4.89 ng/ml, respectively, and IL-6 levels were
170.54 pg/ml and 141.92 pg/ml, respectively. Both concentrations
were signiﬁcantly different between groups. On the other hand,
CRP levels were not signiﬁcantly different between the preterm and
full-term groups. Regarding VEGF as an angiogenic factor, the mean
values for the preterm and full-term groups were 30.76 pg/ml and
22.36 pg/ml, respectively; this represents a signiﬁcant difference
between the groups (Table 2, Fig. 1).
The above values were analyzed for their ability to predict
preterm birth using an ROC curve (Table 3, Fig. 2). ROC analysis was
also used to determine the optimal amniotic ﬂuid levels for MMP-8,
IL-6, and VEGF that would predict preterm delivery. An appropriate
cut-off level for MMP-8 in amniotic ﬂuid was 5.14 ng/ml, with a
sensitivity of 69.4% and a speciﬁcity of 68.3%. For IL-6 in amniotic
ﬂuid, the cut-off value was 134.35 pg/ml, with a sensitivity of 77.8%
and a speciﬁcity of 61.1%. Amniotic VEGF levels had the highest area
under the curve with 0.829. Its predictive cut-off value was
24.995 pg/ml, with a sensitivity of 91.7% and a speciﬁcity of 75.0%.
Fig. 3 shows the representative Western blot results for levels of
mid-trimester amniotic ﬂuid for preterm (Pt2*, Pt3*, Pt5*, and Pt7*)
and full-term (Pt1, Pt4, Pt 6, and Pt8) deliveries of IL-6 (25 kDa),
MMP-8 (85 and 75 kDa, respectively), VEGF (55 and 40 kDa,
respectively), and CRP (120 kDa). The samples were randomly
selected among the subjectsdfour samples from the preterm de-
livery group and four samples from the full-term delivery group.
Amniotic ﬂuid from the preterm delivery group showed thicker and
darker bands of IL-6, MMP-8, and VEGF, but not of CRP.4. Discussion
This study is the ﬁrst to report on a signiﬁcant difference in am-
niotic ﬂuid concentrations of MMP-8, IL-6, and VEGF during the
second trimester in women who underwent preterm delivery
without any other obstetric complications. No signiﬁcant difference
in CRP levels was found between women who had preterm or full-
term deliveries. Several studies of predictive factors for preterm de-
livery point to multiple inﬂammatory biomarkers in mid-trimester
amniotic ﬂuid [3,7e18]. Substantial epidemiological, clinical, micro-
biological, and placental pathology studies support a link between
inﬂammatory states and preterm birth [19]. In this study, we also
found support for a proinﬂammatory response in amniotic ﬂuid that
inﬂuences preterm labor. To the best of our knowledge, this is the
ﬁrst report showing that VEGF levels in amniotic ﬂuid during the
second trimester are predictive of preterm delivery.
Elevated concentrations of CRP in peripheral circulation have
been associated with the presence of intrauterine infection. Some
investigators have noted an elevated amniotic CRP concentration
among women with intrauterine infections compared with studyTable 2
Concentrations of MMP-8, IL-6, CRP, and VEGF measured by ELISA in mid-trimester
amniotic ﬂuid of preterm and term groups.
Preterm delivery
(n ¼ 36)
Term delivery
(n ¼ 36)
p-Valuea
MMP-8 (ng/ml) 5.76  1.53 4.89  1.77 0.028
IL-6 (pg/ml) 170.54  55.69 141.92  57.21 0.035
CRP (ng/ml) 108.431  16.82 102.04  11.77 0.066
VEGF (pg/ml) 30.76  4.06 22.36  7.03 <0.001
Results are expressed as mean  SD.
a Student’s t-test.controls [8,20]. Other reports, however, have concluded that,
though it is a commonly used laboratory parameter, measure-
ment of CRP is nonspeciﬁc and therefore unreliable [7]. More
speciﬁc biomarkers found in mid-trimester amniotic ﬂuiddMMP-
8 and IL-6dare well established from a meta-analysis [3]. During
the course of an inﬂammatory process, IL-6 and MMP-8 accu-
mulate in body ﬂuids (e.g. crevicular, synovial, and amniotic
ﬂuids). We therefore postulate that increased concentrations of
these substances in amniotic ﬂuid can be seen as an index of the
presence of intra-amniotic inﬂammation [15,21]. Although this
process is often present for weeks before preterm delivery, it is
still a reliable marker because inﬂammation should be considered
chronic in nature.
Matrix metalloproteinase-8 (MMP-8), a human neutrophil colla-
genase, is released from the secondarygranules of polymorphonuclear
cells in response to chemotactic stimulation during inﬂammation.
Inﬂammation of amniotic ﬂuid is associated with a dramatic increase
in MMP-8 in patients with intact or ruptured membranes [21].
Because as many as 42% of early preterm deliveries (<32 weeks) can
be associated with an elevated MMP-8 level, intra-amniotic inﬂam-
mation must be considered both frequent and important [14]
The cytokine IL-6 is probably the most investigated and
currently the most established biomarker in amniotic ﬂuid with
regard to intrauterine infection or sterile inﬂammatory immune
activation [22]. Several studies have shown that levels of an am-
niotic IL-6 correlate well with chorioamnion colonization [15].
Amniotic IL-6 levels are thus an excellent marker of intrauterine
inﬂammation that can be evaluated prenatally. IL-6 has also been
demonstrated to be a very sensitive marker of tocolytic resistance
and impending preterm delivery [23]. Nevertheless, there are no
values of MMP-8 and IL-6 for which there is a consensus regarding
a diagnostic level of intrauterine inﬂammation associated with
preterm birth.
Sadowsky et al. demonstrated that infusion of IL-6 into the amni-
otic ﬂuid inpregnantmonkeys did not induce preterm birth [24]. This
suggests that preterm labor may be induced not by a single inﬂam-
matory or immune substance, but by interactions between multiple
substances or pathways. In contrast to acute inﬂammation, chronic
inﬂammation causes substantial tissue damage, which may lead to
procarcinogenic conditions [5]. In this situation, pathological angio-
genesis can be promoted through a continuous recruitment of sub-
stances, thereby exacerbating inﬂammation and damage [25].
Furthermore, under hypoxic conditions, recruited inﬂammatory cells,
such as neutrophils, eosinophils, mast cells, NK cells, and macro-
phages, secrete proangiogenic factors, includingVEGF, tumornecrosis
factor-alpha, and other cytokines, increasing vascular permeability
and facilitating additional recruitment of immune cells [26]. The
precise molecular mechanisms by which reproductive tract in-
fections/inﬂammation induce vascular changes that promote leuko-
cyte trafﬁcking and disruption of vascular integrity that is associated
with abruption have yet to be fully elucidated [19]
VEGF belongs to a family of heparin-binding growth factors that
play an important role in vasculogenesis, angiogenesis, and vascular
permeability throughout the body. Although VEGF alone does not
activate the endothelium to induce cell-adhesion molecule expres-
sion, it sensitizes endothelial cells to proinﬂammatory cytokines that
upregulate E-selectin, a key mediator of leukocyte trafﬁcking [27].
VEGF, which is abundantly expressed by decidual cells, induces
vascular fenestrations and a prothrombotic surface on endometrial
endothelial cells [28]. Taken together, these data suggest that VEGF
signaling at the maternalefetal interface is a critical mediator of
inﬂammation that can be linked to preterm labor. Brou et al. resulted
that VEGF concentrations in fetal plasma are signiﬁcantly higher in
cases of preterm birth, and suggested the possible role of VEGF for
preterm labor pathway [29].
Fig. 1. Concentrations of MMP-8, IL-6, CRP, and VEGF as measured by ELISA in mid-trimester amniotic ﬂuid in preterm and full-term delivery groups.
A. Kim et al. / Placenta 34 (2013) 873e878876This study provides an early demonstration of a possible pre-
term labor-instigating association or interaction between the in-
ﬂammatory mediators, MMP-8 and IL-6, and the angiogenic
biomarker, VEGF, in amniotic ﬂuid. The concentrations measured
through ELISA were conﬁrmed by adjunctive Western blotting,
which is a widely accepted analytical technique used to detect
speciﬁc proteins in this type of tissue homogenate or extract
(Fig. 3). VEGF expression in infected placental tissues appears to be
localized primarily to decidual stromal cells [19]. Amniotic ﬂuid
inﬂammation is related to chorioamnionitis, and in this condition,
decidual cells at the maternalefetal interface can upregulate
VEGF production or an associated pathway to alter vascular
permeability. As a result, inﬂammation of amniotic ﬂuid canFig. 2. Receiver operating characteristic (ROC) curves that compare the values of MMP-
8, IL-6, CRP, and VEGF for preterm delivery.
Table 3
Receiver operating characteristic analysis with the concentrations of MMP-8, IL-6,
CRP, and VEGF measured by ELISA in mid-trimester amniotic ﬂuid.
Preterm delivery (n ¼ 36) vs. term delivery (n ¼ 36)
Area under
curve
95% CI P-value Cut-off value
MMP-8 (ng/ml) 0.637 0.509e0.766 0.045 5.14
IL-6 (pg/ml) 0.650 0.517e0.782 0.029 134.35
CRP (ng/ml) 0.608 0.476e0.740 0.115
VEGF (pg/ml) 0.829 0.722e0.935 <0.001 24.995
Fig. 3. Representative Western blot for preterm (Pt2*, Pt3*, Pt5*, and Pt7*) and full-
term (Pt1, Pt4, Pt6, and Pt8) groups showing levels of IL-6 (25 kDa), MMP-8 (85 and
75 kDa, respectively), VEGF (55 and 40 kDa, respectively), and CRP (120 kDa) in mid-
trimester amniotic ﬂuid.
A. Kim et al. / Placenta 34 (2013) 873e878 877promote extravasation into the decidua of immune cells, leading to
‘‘decidual activation,’’ all of which promote preterm birth.
The lack of blinding of patient test results in previous studies is
particularly relevant because women with abnormal results might
have received more intensive follow-up or therapeutic care than
women with normal results, which would have biased an evalua-
tion of the test’s predictive accuracy. One strength of this study is
the fact that we did not know or compare the levels of target
molecules in the amniotic ﬂuid until the termination of pregnancy.
Another strength is the homogeneity of the participant population,
since it is a complex phenotype that is related to multiple mecha-
nisms, including infection/inﬂammation, uteroplacental ischemia
or hemorrhage, uterine overdistension, stress, and other immu-
nologically mediated processes [30]. We homogenized the preterm
delivery group by including only patients with spontaneous pre-
term delivery <37 weeks of gestation in singleton pregnancy.
A reliable predictor of spontaneous preterm birth is important
because it could allow for the identiﬁcation of women at high risk
of preterm birth, in whom a speciﬁc intervention could be tested.
Being able to predict which women are likely to have a preterm
birth is a prerequisite for the effective use of most interventions
aimed at preventing preterm birth. Also, studies that identify pre-
dictors of spontaneous preterm birth may improve our under-
standing of the mechanisms of biological and disease pathways
that lead to it and possibly lead to better interventions. Further-
more, they can give the clue of predictivemarkers with noninvasive
methods, unlike amniocentesis. Finally, another reason for pre-
dicting preterm birth is that being able to identify womenwith low
risk would avoid unnecessary and costly interventions [3]. This
strategy may prevent both the initiation of preterm labor and the
fetal complications associated with a pathological process that is
silent at mid-trimester but leads to preterm delivery. Patients
identiﬁed through these methods can be followed and monitored
with technologies, such as cervical sonography, and treated with
interventions to reduce the rate of preterm delivery.
We evaluated the cut-off values for useful biomarkers to predict
preterm birth in mid-trimester amniotic ﬂuid. The values were
5.14 ng/ml, 134.35 pg/ml, and 24.995 pg/ml for MMP-8, IL-6, and
VEGF, respectively. These levels cannot yet be applied in clinical
work; further studies are needed to replicate and corroborate these
results. It seems to have variability in biomarker levels over time or
between individuals, making it difﬁcult to determine the threshold
level for risk of spontaneous preterm birth. Indeed, the combined use
of markers has been shown to have better predictive accuracy thanindividual markers alone because there are several heterogeneous
pathways that lead to spontaneous preterm birth, including inﬂam-
matory and angiogenic responses. Further prospective, large-scale,
longitudinal studies are needed to determine the novel biomarkers
that have more predictive accuracy, alone or combination.
We excluded the women with complications, which can cause
preterm labor, such as pre-eclampsia, obstetrical hemorrhage, or
premature preterm rupture of membrane. In general population,
many maternal or fetal conditions can lead to preterm birth. The
analysis of MMP-8, IL-6, and VEGF concentrations in amniotic ﬂuid
of women with those conditions may give us more information for
preterm labor with or without obstetric complications. It must be
preceded as further study for clinical application to predict preterm
birth in general pregnant women.
In conclusion, the diagnostic value of CRP in mid-trimester
amniotic ﬂuid for spontaneous preterm birth is questionable.
However, despite still unrevealed mechanisms, elevated inﬂam-
matory mediators, MMP-8 and IL-6, are associated with preterm
birth among women with an intact membrane. Elevated concen-
tration of VEGF as angiogenic parameter is also related to preterm
birth. This analogizes the interaction between inﬂammation and
angiogenic pathways in amniotic ﬂuid and the maternalefetal
interface to promote spontaneous preterm labor.Conﬂicts of interest
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